| Overview |
| bs-14473R-Cy3 |
| Big dynorphin Polyclonal Antibody, Cy3 Conjugated |
| IF(IHC-P) |
| Human, Mouse, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Big dynorphin |
| 207-254/254 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5173 |
| P01213 |
| Dynorphin B; Beta-neoendorphin-dynorphin; Big dynorphin; Big Dyn; Dyn B; Dyn-B; Dynorphin B; Dynorphin B(1-13); Dynorphin B-29; Leumorphin; PDYN; PDYN_HUMAN; Preprodynorphin. |
| The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010] |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz